CRS occurs as a result of massive cytokine release from activated T cells, primarily interleukin-6 (IL-6), and interferon-gamma (IFN-γ), which are critical in the pathophysiology of this adverse event (68). The gene discussed is IL6; the disease is congenital rubella syndrome.